Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Deloitte
UBS
Express Scripts
Medtronic
Farmers Insurance
Argus Health
Chinese Patent Office
Moodys

Generated: April 23, 2018

DrugPatentWatch Database Preview

PATHILON Drug Profile

« Back to Dashboard

Which patents cover Pathilon, and what generic alternatives are available?

Pathilon is a drug marketed by Lederle and is included in two NDAs.

The generic ingredient in PATHILON is tridihexethyl chloride. Additional details are available on the tridihexethyl chloride profile page.
Summary for PATHILON
US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: 12
Patent Applications: 472
Drug Prices:see details
DailyMed Link:PATHILON at DailyMed
Drug patent expirations by year for PATHILON
Synonyms for PATHILON
(3-cyclohexyl-3-hydroxy-3-phenylpropyl)-triethylazanium chloride
(3-cyclohexyl-3-hydroxy-3-phenylpropyl)-triethylazanium;chloride
(3-Cyclohexyl-3-hydroxy-3-phenylpropyl)triethylammonium chloride
3-cyclohexyl-N,N,N-triethyl-3-hydroxy-3-phenylpropan-1-aminium chloride
4310-35-4
60-49-1 (Parent)
AC1L2FZ7
ACM4310354
AMMONIUM, (3-CYCLOHEXYL-3-HYDROXY-3-PHENYLPROPYL)TRIETHYL-, CHLORIDE
BENZENEPROPANAMINIUM, G-CYCLOHEXYL-N,N,N-TRIETHYL-G-HYDROXY-
Benzenepropanaminium, gamma-cyclohexyl-N,N,N-triethyl-gamma-hydroxy-, chloride
C21H36NO.Cl
CAS-4310-35-4
CCG-221042
CHEBI:9703
CHEMBL1200771
D00723
DSSTox_CID_3701
DSSTox_GSID_23701
DSSTox_RID_77155
DTXSID4023701
EINECS 224-323-3
HMS1571A06
HMS2098A06
HMS2233A09
HMS3373K12
LS-17260
MLS002154119
NCGC00017006-01
OR069671
OR293445
Pathilon (TN)
Pathilon chloride
SCHEMBL100471
SMR001233426
SR-01000838833
SR-01000838833-2
Tox21_110733
Tridihexethyl chloride
TRIDIHEXETHYL CHLORIDE (200 MG)
Tridihexethyl chloride (BAN)
Tridihexethyl chloride [BAN]
Tridihexethyl chloride [USP:INN:BAN]
Tridihexethyl chloride(200 mg)

US Patents and Regulatory Information for PATHILON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle PATHILON tridihexethyl chloride INJECTABLE;INJECTION 009729-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lederle PATHILON tridihexethyl chloride TABLET;ORAL 009489-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Department of Justice
Express Scripts
Queensland Health
Harvard Business School
Federal Trade Commission
UBS
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.